Related Experiment Video
Updated: Oct 14, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Hepatitis B Screening Before Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drug Therapy: Many Roads
Alfredo Aguirre1, Jinoos Yazdany2
1A. Aguirre, MD, Clinical Fellow, J. Yazdany, MD, MPH, Professor, Division of Rheumatology, University of California, San Francisco, California, USA. alfredo.aguirre@ucsf.edu.
No abstract available in PubMed .
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

